ADICET BIO INC has a total of 57 patent applications. It decreased the IP activity by 55.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SANGAMO THERAPEUTICS FRANCE, SUZHOU STAINWEI BIOTECH INC and UNUM THERAPEUTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Canada | 8 | |
#3 | Australia | 6 | |
#4 | China | 6 | |
#5 | EPO (European Patent Office) | 6 | |
#6 | Republic of Korea | 6 | |
#7 | Mexico | 5 | |
#8 | United States | 5 | |
#9 | Israel | 3 | |
#10 | Singapore | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Jakobovits Aya | 34 |
#2 | Foord Orit | 30 |
#3 | Denkberg Galit | 23 |
#4 | Sinik Keren | 23 |
#5 | Reiter Yoram | 23 |
#6 | Peled Kamar Mira | 23 |
#7 | Oren Ravit | 23 |
#8 | Erel Segal Reut | 23 |
#9 | Alishekevitz Dror Shmuel | 23 |
#10 | Beer Ilan | 22 |
Publication | Filing date | Title |
---|---|---|
WO2020117862A1 | Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof | |
CA3115139A1 | Compositions and methods regarding engineered and non-engineered .gamma..delta.-t cells for treatment of hematological tumors | |
WO2020072546A2 | COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED γδ -T CELLS FOR TREATMENT OF SOLID TUMORS | |
KR20200098518A | Method for selective proliferation of δ3 γδ T-cell population and composition thereof | |
AU2017418590A1 | Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof | |
AU2017261804A1 | Methods for selective expansion of γδ T-cell populations and compositions thereof | |
KR20180011275A | T-cell receptor-like antibodies with excellent specificity | |
US2018179283A1 | T cell receptor like antibodies having fine specificity | |
EP3220926A2 | Engineered gamma delta t-cells |